| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/06/2005 | US20050005311 High throughput screening for cancer genes |
| 01/06/2005 | US20050005310 Expression vectors and methods |
| 01/06/2005 | US20050004355 Diagnosing immune system disorders using defensin specific immuoglobulin; microbiocides and treatment of respiratory system disorders |
| 01/06/2005 | US20050004351 Therapeutic and diagnostic domain 1 beta2GP1 polypeptides and methods of using same |
| 01/06/2005 | US20050004349 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/06/2005 | US20050004348 Sodium transport protein for use as tool in identifying modulator for treatment of hyperphosphatemia or hypophosphatemia |
| 01/06/2005 | US20050004230 Retroviral protease inhibitors |
| 01/06/2005 | US20050004066 Monoclonal antibodies specific to VEGF receptors and uses thereof |
| 01/06/2005 | US20050004065 Hypoxia regulated genes |
| 01/06/2005 | US20050004063 nucleotide sequence which was designed based on portions of the genomic sequences of the different strains of the hSARS virus and their use as therapeutic agents in therapeutic methods |
| 01/06/2005 | US20050004061 Immunostimulatory nucleic acid molecules |
| 01/06/2005 | US20050004058 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 01/06/2005 | US20050004041 Obtained by hydrolysis of casein; hypotensive agents; foods, drugs |
| 01/06/2005 | US20050004040 Peptide having an affinity for gp120 |
| 01/06/2005 | US20050004035 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 01/06/2005 | US20050004034 Human C-Maf compositions and methods of use therefor |
| 01/06/2005 | US20050004032 COMPRISING TRIPEPTIDE UNIT OF THE FORMULA (flp-Yaa-Gly)N, WHERE Yaa IS ANY AMINO ACID, FLP IS 4(R)-FLUORO-L-PROLINE, AND N IS AT LEAST 3; INCREASED STABILITY; STRONGER TRIPLE HELIX THAN NATIVE COLLAGEN; FOR USE SUCH AS IN ARTIFICIAL SKIN |
| 01/06/2005 | US20050004030 Degradation spores; infection therapy |
| 01/06/2005 | US20050004028 modulating cell growth, cell differentiation, or cell survival; genetic engineering using hedgehog genes and proteins; neurodegenerative diseases; tissue-targeted therapy |
| 01/06/2005 | US20050004027 Administering a compound which blocks endothelial growth factor |
| 01/06/2005 | US20050004022 Cognition activators; neuropathic pain; contacting cells with erythropoietin protein |
| 01/06/2005 | US20050004021 Enzyme inhibitor for therapy of thrombosis, blood disorders |
| 01/06/2005 | US20050004019 Neuroprotective peptides and uses thereof |
| 01/06/2005 | US20050004017 Antiproliferative agents; anticarcinogenic agents |
| 01/06/2005 | US20050004016 Quantitative analysis of amino acid sequences; genetic engineering |
| 01/06/2005 | US20050004015 Novel haemopoietin receptor and genetic sequences encoding same |
| 01/06/2005 | US20050004013 Selective R-cadherin antagonist and methods |
| 01/06/2005 | US20050004000 Oral absorbed drugs |
| 01/06/2005 | US20050003546 Viral uptake into cells and tissues |
| 01/06/2005 | US20050003539 Plasmid maintenance system for antigen delivery |
| 01/06/2005 | US20050003512 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/06/2005 | US20050003510 Transgenic lactobacillus which has been modified to express heterologous gene products on cell wall surface for use as therapeutic tool in prevention of bacterial infection and inflammatory response |
| 01/06/2005 | US20050003505 delivering genes; gag genes, gag protein; endothelial growth factor |
| 01/06/2005 | US20050003494 Mutated gene from corynebacterium glutamicum |
| 01/06/2005 | US20050003492 Novel polypeptide |
| 01/06/2005 | US20050003491 Secreted proteins and polynucleotides encoding them |
| 01/06/2005 | US20050003490 Immunoglobulins specific for cell surface protein for use in diagnosis, prevention and treatment of cell proliferative disorders; inhibitory action associated with reduced cellular transport of amino acids |
| 01/06/2005 | US20050003489 Conformational and topological protein regulation |
| 01/06/2005 | US20050003488 Polypeptide, cDNA encoding the same, and use of them |
| 01/06/2005 | US20050003484 Modified antigen-presenting cells |
| 01/06/2005 | US20050003483 Major histocompatibility complex peptide ligand for use in identifying modulators which prevent transplantation and autoimmunity disorders; immunotherapy |
| 01/06/2005 | US20050003481 Novel glutamic acid receptor and utilization thereof |
| 01/06/2005 | US20050003480 Tumor necrosis factor variant for use in the treatment and prevention of cell proliferative disorders |
| 01/06/2005 | US20050003477 Expression vector comprising nucleotide sequences coding brain cyclic nucleotide gated ion channel (BCNG) protein for use in treatment and prevention of nervous system, urogenital and cardiovascular disorders |
| 01/06/2005 | US20050003475 Soluble interleukin-20 receptor |
| 01/06/2005 | US20050003473 Aspergillus ochraceus 11 alpha hydroxylase and oxidoreductase |
| 01/06/2005 | US20050003466 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 01/06/2005 | US20050003465 Monoclonal abtibody specific to prostate cell-surface antigen associated with androgen-dependent and androgen-independent prostate tumors for use in prevention, diagnosis and treatment of cell proliferative disorders; immunodiagnostics; immunotherapy |
| 01/06/2005 | US20050003457 Immunoglobulin which binds osteoclastogenesis inhibitory factor binding molecules (OBM)) and prevents bone resorption for use in treatment and prevention of bone disorders |
| 01/06/2005 | US20050003454 Conformational and topological protein regulation |
| 01/06/2005 | US20050003453 G-CSF analog compositions and methods |
| 01/06/2005 | US20050003452 Fusion protein comprising membrane translocation sequences for use in identifying modulators for treatment and prevention of cell proliferative disorders |
| 01/06/2005 | US20050003451 Immunoglobulin for use in diagnosis, prevention and treatment of infection, autoimmune, inflammatory and cell proliferative diseases; immunotherapy |
| 01/06/2005 | US20050003450 Immunoaffinity isolation of modified peptides from complex mixtures |
| 01/06/2005 | US20050003447 Cell matrix protein for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, vesicle trafficking, neurological, cell motility, reproductive,and muscle disorders. |
| 01/06/2005 | US20050003445 Alterations in the long QT syndrome genes KVLQT1 and SCN5A and methods for detecting same |
| 01/06/2005 | US20050003444 Novel human polynucleotides and the polypeptides encoded thereby |
| 01/06/2005 | US20050003443 Oligonucleotide sequences for use as tools in gene discovery, gene expression analysis, forensics and disease diagnosis |
| 01/06/2005 | US20050003439 Mutations in the KCNE1 gene encoding human minK which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
| 01/06/2005 | US20050003438 Conformational and topological protein regulation |
| 01/06/2005 | US20050003437 Human oncogene induced secreted protein I |
| 01/06/2005 | US20050003433 Recombinant neospora antigens and their uses |
| 01/06/2005 | US20050003431 Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor |
| 01/06/2005 | US20050003427 Dendritic enriched secreted lymphocyte activation molecule |
| 01/06/2005 | US20050003426 Nucleotide sequences coding zinc finger protein comprising repeat sequences for use as tool in diagnosing and treating muscular disorders |
| 01/06/2005 | US20050003425 Nucleotide sequences coding tumor marker protein for use in diagnosis and/or prognosis of cell proliferative disorders |
| 01/06/2005 | US20050003424 Nucleotide sequences coding ligand-binding receptor polypeptide for use in treating and preventing male sterility; for identifying modulators which can be used as male contraceptives |
| 01/06/2005 | US20050003423 Expression vector comprising polynucleotide sequences coding transcriptional regulator associated with lysine biosynthesis for use in generation of transgenic bacterial cells with enhanced lysine biosynthesis; for enhancing animal feeds, cosmetics and medicines |
| 01/06/2005 | US20050003414 Expression vector comprising artificial chromosome and and avian regulatory sequences for use as tool in heterologous gene transfer and expression |
| 01/06/2005 | US20050003407 Genomic DNA fragments containing regulatory and coding sequence for the beta2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
| 01/06/2005 | US20050003403 Multimeric protien for use in treatment and prevention of infections, nervous system, inflammatory, autoimmune and cell proliferative disorders |
| 01/06/2005 | US20050003402 Nucleotide sequences coding protein transiently associated with the kinetochore complex during mitosis for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 01/06/2005 | US20050003401 Expression vector comprising nucleotide sequences coding archaeal replication factor A (RFA) for use in generating polypeptide which enhances stability and efficacy of gene amplification products |
| 01/06/2005 | US20050003400 Using osteoprotegrin binding agent as tool in identifying modulator for treatment and prevention of osteoporosis and bone disorders |
| 01/06/2005 | US20050003391 Bioassay for detection of receptor activated nuclear factor kappa beta ligand (RANKL); identifying modulator immune and inflammatory response |
| 01/06/2005 | US20050003387 Using tumor necrosis factor-related apoptosis-inducing ligand as a tool to identify modulators of programmed cell death for use in treatment of cell proliferative disorders |
| 01/06/2005 | US20050003385 Diagnosing nervous system disorders via presence of mutation/polymorphism in parkin gene |
| 01/06/2005 | US20050003384 Surface expression libraries of heteromeric receptors |
| 01/06/2005 | US20050003370 Expression vector comprising nucleotide sequences coding membrane receptor proteins for use in identifying modulators for treatment and prevention of cell proliferative, nervous system, reproductive cardiovascular and inflammation disorders |
| 01/06/2005 | US20050003367 Methods and compositions for rapid development of screening assays |
| 01/06/2005 | US20050003365 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo |
| 01/06/2005 | US20050003364 Using gene expression profiles as diagnostic tool in detection of cardiac, renal and inflammatory disease |
| 01/06/2005 | US20050003363 Method of screening for agents inhibiting chloride intracellular channels |
| 01/06/2005 | US20050003358 Novel cancer marker and uses therefor in the diagnosis of cancer |
| 01/06/2005 | US20050003353 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/06/2005 | US20050003352 Comprises recombinant mitochondrial transport protein for diagnosis, prevention and treatment of alzheimer's, diabetes, parkinson's, huntington's, cancers |
| 01/06/2005 | US20050003349 High titer recombinant influenza viruses for vaccines and gene therapy |
| 01/06/2005 | US20050003348 Drug screening/design; crystal structure; replication-defective |
| 01/06/2005 | US20050003345 Synthetic antigens for the detection of antibodies to hepatitis C virus |
| 01/06/2005 | US20050003344 Adeno-associated viral deletion rep protein comprising functional nuclear localization sequence for use delivery of gene products to preferential intracellular locations |
| 01/06/2005 | US20050003342 Using polymorphic sequences to identify, classify and monitor viral infection of horses; animal husbandry and veterinary medicine; genetic vaccines; immunotherapy |
| 01/06/2005 | US20050003329 Interactive dental restorative network |
| 01/06/2005 | US20050002968 Flavivirus vaccines |
| 01/06/2005 | US20050002966 Attenuated pestiviruses |
| 01/06/2005 | US20050002960 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 01/06/2005 | US20050002957 Long lasting immunity to variety of Neisseria meningitidis strains |
| 01/06/2005 | US20050002955 Acquired Immune Deficiency Syndrome (AIDS) diagnosis and treatment |
| 01/06/2005 | US20050002953 Recombinant vectors expressing E, M and/or S proteins; cell line |
| 01/06/2005 | US20050002950 Vaccine preventing infection |
| 01/06/2005 | US20050002946 Vaccines and agents for inducing immunity in fish against rickettsial diseases, and associated preventative therapy |